- /
- Supported exchanges
- / US
- / SNZZF.OTCGREY
Senzime AB (publ) (SNZZF OTCGREY) stock market data APIs
Senzime AB (publ) Financial Data Overview
Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. The company offers TetraGraph, quantitative train of-four (TOF) monitoring refined by real-world patient data; and ExSpiron, a non-invasive monitoring system that uses bioelectrical impedance sensor to measure the tissue's opposition to carrying an alternating electrical current. It also provides additional products, including CliniSenz Analyzer and OnZurf Probe. The company has a strategic connectivity and licensing agreement with Masimo that grants Senzime the rights to use some of Masimo's intellectual property; license agreement with Fukuda Denshi Co. Ltd. to license TetraGraph technology; and license agreement with CoreSpiron (Henan) Co Ltd. to manufacture and sell ExSpiron system. Senzime AB (publ) was incorporated in 1999 and is headquartered in Uppsala, Sweden.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Senzime AB (publ) data using free add-ons & libraries
Get Senzime AB (publ) Fundamental Data
Senzime AB (publ) Fundamental data includes:
- Net Revenue: 89 707 K
- EBITDA: -100 475 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-10-29
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Senzime AB (publ) News
New
Senzime AB (publ) GAAP EPS of -SEK0.07, revenue of TSEK30.09
* Senzime AB (publ) press release [https://seekingalpha.com/pr/20704800-senzime-q3-2026-continued-strong-sensor-sales-and-growth-in-all-segions-clear-progress] (SNZZF [https://seekingalpha.com/symbo...
Senzime Q3 2026: Continued Strong Sensor Sales and Growth in All Segions. Clear Progress Towards Profitability
UPPSALA, SE / ACCESS Newswire / October 29, 2026 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB's (publ) interim report for July - September (Q3) 2026 is now available on the company's website www.sen...
New Scientific Evidence Presented at ANESTHESIOLOGY 2026 Strengthens the Case for Senzime's TetraGraph and Quantitative Neuromuscular Monitoring
UPPSALA, SE AND SAN DIEGO, CA / ACCESS Newswire / October 17, 2026 / Senzime (STO:SEZI) (OTCQX:SNZZF) Senzime AB (publ), a global leader in precision-based patient monitoring solutions, today announce...
ElevenLabs doubles valuation to $22B after recent $300M employee tender offer
[AI chip with colorful circuit lines flowing through the circuits] cgtoolbox/iStock via Getty Images Artificial intelligence voice startup ElevenLabs disclosed on Wednesday that its valuation has dou...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.